Copyright Reports & Markets. All rights reserved.

Global Killed-type Poultry Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Killed-type Poultry Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 NDV
    • 1.3.3 Marek ' s Disease
    • 1.3.4 IBD
    • 1.3.5 Infectious Bronchitis
    • 1.3.6 Influenza
    • 1.3.7 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Killed-type Poultry Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Chicken
    • 1.4.3 Other Poultry
  • 1.5 Global Killed-type Poultry Vaccine Market Size & Forecast
    • 1.5.1 Global Killed-type Poultry Vaccine Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Killed-type Poultry Vaccine Sales Quantity (2020-2031)
    • 1.5.3 Global Killed-type Poultry Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 MERCK
    • 2.1.1 MERCK Details
    • 2.1.2 MERCK Major Business
    • 2.1.3 MERCK Killed-type Poultry Vaccine Product and Services
    • 2.1.4 MERCK Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 MERCK Recent Developments/Updates
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Killed-type Poultry Vaccine Product and Services
    • 2.2.4 Boehringer Ingelheim Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.3 CEVA
    • 2.3.1 CEVA Details
    • 2.3.2 CEVA Major Business
    • 2.3.3 CEVA Killed-type Poultry Vaccine Product and Services
    • 2.3.4 CEVA Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 CEVA Recent Developments/Updates
  • 2.4 ZOETIS
    • 2.4.1 ZOETIS Details
    • 2.4.2 ZOETIS Major Business
    • 2.4.3 ZOETIS Killed-type Poultry Vaccine Product and Services
    • 2.4.4 ZOETIS Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 ZOETIS Recent Developments/Updates
  • 2.5 Vaxxinova
    • 2.5.1 Vaxxinova Details
    • 2.5.2 Vaxxinova Major Business
    • 2.5.3 Vaxxinova Killed-type Poultry Vaccine Product and Services
    • 2.5.4 Vaxxinova Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Vaxxinova Recent Developments/Updates
  • 2.6 ELANCO
    • 2.6.1 ELANCO Details
    • 2.6.2 ELANCO Major Business
    • 2.6.3 ELANCO Killed-type Poultry Vaccine Product and Services
    • 2.6.4 ELANCO Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 ELANCO Recent Developments/Updates
  • 2.7 QYH BIOTECH
    • 2.7.1 QYH BIOTECH Details
    • 2.7.2 QYH BIOTECH Major Business
    • 2.7.3 QYH BIOTECH Killed-type Poultry Vaccine Product and Services
    • 2.7.4 QYH BIOTECH Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 QYH BIOTECH Recent Developments/Updates
  • 2.8 PULIKE
    • 2.8.1 PULIKE Details
    • 2.8.2 PULIKE Major Business
    • 2.8.3 PULIKE Killed-type Poultry Vaccine Product and Services
    • 2.8.4 PULIKE Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 PULIKE Recent Developments/Updates
  • 2.9 PHIBRO ANIMAL HEALTH CORPORATION
    • 2.9.1 PHIBRO ANIMAL HEALTH CORPORATION Details
    • 2.9.2 PHIBRO ANIMAL HEALTH CORPORATION Major Business
    • 2.9.3 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Product and Services
    • 2.9.4 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
  • 2.10 JINYU BIOTECHNOLOGY
    • 2.10.1 JINYU BIOTECHNOLOGY Details
    • 2.10.2 JINYU BIOTECHNOLOGY Major Business
    • 2.10.3 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Product and Services
    • 2.10.4 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
  • 2.11 HARBIN PHARMACEUTICAL GROUP
    • 2.11.1 HARBIN PHARMACEUTICAL GROUP Details
    • 2.11.2 HARBIN PHARMACEUTICAL GROUP Major Business
    • 2.11.3 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Product and Services
    • 2.11.4 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
  • 2.12 MEVAC
    • 2.12.1 MEVAC Details
    • 2.12.2 MEVAC Major Business
    • 2.12.3 MEVAC Killed-type Poultry Vaccine Product and Services
    • 2.12.4 MEVAC Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 MEVAC Recent Developments/Updates
  • 2.13 VENKY’S
    • 2.13.1 VENKY’S Details
    • 2.13.2 VENKY’S Major Business
    • 2.13.3 VENKY’S Killed-type Poultry Vaccine Product and Services
    • 2.13.4 VENKY’S Killed-type Poultry Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 VENKY’S Recent Developments/Updates

3 Competitive Environment: Killed-type Poultry Vaccine by Manufacturer

  • 3.1 Global Killed-type Poultry Vaccine Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Killed-type Poultry Vaccine Revenue by Manufacturer (2020-2025)
  • 3.3 Global Killed-type Poultry Vaccine Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Killed-type Poultry Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Killed-type Poultry Vaccine Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Killed-type Poultry Vaccine Manufacturer Market Share in 2024
  • 3.5 Killed-type Poultry Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Killed-type Poultry Vaccine Market: Region Footprint
    • 3.5.2 Killed-type Poultry Vaccine Market: Company Product Type Footprint
    • 3.5.3 Killed-type Poultry Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Killed-type Poultry Vaccine Market Size by Region
    • 4.1.1 Global Killed-type Poultry Vaccine Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Killed-type Poultry Vaccine Consumption Value by Region (2020-2031)
    • 4.1.3 Global Killed-type Poultry Vaccine Average Price by Region (2020-2031)
  • 4.2 North America Killed-type Poultry Vaccine Consumption Value (2020-2031)
  • 4.3 Europe Killed-type Poultry Vaccine Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Killed-type Poultry Vaccine Consumption Value (2020-2031)
  • 4.5 South America Killed-type Poultry Vaccine Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Killed-type Poultry Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 5.2 Global Killed-type Poultry Vaccine Consumption Value by Type (2020-2031)
  • 5.3 Global Killed-type Poultry Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 6.2 Global Killed-type Poultry Vaccine Consumption Value by Application (2020-2031)
  • 6.3 Global Killed-type Poultry Vaccine Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 7.2 North America Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 7.3 North America Killed-type Poultry Vaccine Market Size by Country
    • 7.3.1 North America Killed-type Poultry Vaccine Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Killed-type Poultry Vaccine Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 8.2 Europe Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 8.3 Europe Killed-type Poultry Vaccine Market Size by Country
    • 8.3.1 Europe Killed-type Poultry Vaccine Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Killed-type Poultry Vaccine Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Killed-type Poultry Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Killed-type Poultry Vaccine Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Killed-type Poultry Vaccine Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 10.2 South America Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 10.3 South America Killed-type Poultry Vaccine Market Size by Country
    • 10.3.1 South America Killed-type Poultry Vaccine Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Killed-type Poultry Vaccine Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Killed-type Poultry Vaccine Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Killed-type Poultry Vaccine Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Killed-type Poultry Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Killed-type Poultry Vaccine Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Killed-type Poultry Vaccine Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Killed-type Poultry Vaccine Market Drivers
  • 12.2 Killed-type Poultry Vaccine Market Restraints
  • 12.3 Killed-type Poultry Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Killed-type Poultry Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Killed-type Poultry Vaccine
  • 13.3 Killed-type Poultry Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Killed-type Poultry Vaccine Typical Distributors
  • 14.3 Killed-type Poultry Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Killed-type Poultry Vaccine market size was valued at US$ 3408 million in 2024 and is forecast to a readjusted size of USD 4531 million by 2031 with a CAGR of 4.2% during review period.
    According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 589%.
    This report is a detailed and comprehensive analysis for global Killed-type Poultry Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Killed-type Poultry Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Killed-type Poultry Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Killed-type Poultry Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Killed-type Poultry Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Killed-type Poultry Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Killed-type Poultry Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Killed-type Poultry Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    NDV
    Marek ' s Disease
    IBD
    Infectious Bronchitis
    Influenza
    Other
    Market segment by Application
    Chicken
    Other Poultry
    Major players covered
    MERCK
    Boehringer Ingelheim
    CEVA
    ZOETIS
    Vaxxinova
    ELANCO
    QYH BIOTECH
    PULIKE
    PHIBRO ANIMAL HEALTH CORPORATION
    JINYU BIOTECHNOLOGY
    HARBIN PHARMACEUTICAL GROUP
    MEVAC
    VENKY’S
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Killed-type Poultry Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Killed-type Poultry Vaccine, with price, sales quantity, revenue, and global market share of Killed-type Poultry Vaccine from 2020 to 2025.
    Chapter 3, the Killed-type Poultry Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Killed-type Poultry Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Killed-type Poultry Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Killed-type Poultry Vaccine.
    Chapter 14 and 15, to describe Killed-type Poultry Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now